Brief: Xortx Therapeutics To Consolidate Shares 1-For-5 Effective April 6, 2026
April 1 (Reuters) - XORTX Therapeutics Inc XRTX.V: XORTX THERAPEUTICS INC - TO CONSOLIDATE SHARES 1-FOR-5 EFFECTIVE APRIL 6, 2026 Source text: ID:nGNXb1gQSJ Further company coverage: XRTX.V ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Outlines Anticipated Health Canada Clinical Trial Application For Xrx-026 For Gout
Brief: XORTX Therapeutics Announces Initiation Of Drug And Tablet Manufacturing For XRx-026 Program
Brief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering